Market Exclusive

Analyst Upgrades – Quest Diagnostics Incorporated (NYSE:DGX) Stock Gets Upgraded By Bank of America Corporation from Neutral to Buy

Analyst Ratings For Quest Diagnostics Incorporated (NYSE:DGX)

Today, Quest Diagnostics Incorporated (NYSE:DGX) stock received an upgrade by Bank of America Corporation from Neutral to Buy.

There are 7 hold ratings, 6 buy ratings, 1 strong buy rating on the stock.

The current consensus rating on Quest Diagnostics Incorporated (NYSE:DGX) is Buy (Score: 2.57) with a consensus target price of $108.54 per share, a potential 0.83% downside.

Some recent analyst ratings include

Dividend information for Quest Diagnostics Incorporated (NYSE:DGX)

Quest Diagnostics Incorporated (NYSE:DGX) pays an annual dividend of Community Ranking: with a yield of 1.64% and an average dividend growth of 9.60% based on a 3 Year Average.

Dividend History for Quest Diagnostics Incorporated (NYSE:DGX)

Recent Insider Trading Activity For Quest Diagnostics Incorporated (NYSE:DGX)
Quest Diagnostics Incorporated (NYSE:DGX) has insider ownership of 1.50% and institutional ownership of 90.81%.

Recent Trading Activity for Quest Diagnostics Incorporated (NYSE:DGX)
Shares of Quest Diagnostics Incorporated closed the previous trading session at 107.19 down -2.25 -2.06% with 1,008,110 shares trading hands.

Exit mobile version